170804-18-9 Usage
Uses
Used in Chemical Reactions:
ETHYL 3-AMINO-4,4,4-TRIFLUOROBUTYRATE is used as a reactant for [specific chemical reactions] due to its unique chemical configuration and the presence of the trifluorobutyrate and amino group.
Used in Pharmaceutical Industry:
ETHYL 3-AMINO-4,4,4-TRIFLUOROBUTYRATE is used as an intermediate in the synthesis of pharmaceutical compounds for [specific therapeutic applications], leveraging its fluorination and reactivity in chemical processes.
Used in Material Science:
ETHYL 3-AMINO-4,4,4-TRIFLUOROBUTYRATE is used as a building block in the development of new materials with [desired properties], such as enhanced stability or specific interactions, due to its fluorinated structure.
Used in Agrochemical Industry:
ETHYL 3-AMINO-4,4,4-TRIFLUOROBUTYRATE is used as a precursor in the production of agrochemicals for [agricultural applications], taking advantage of its reactivity and potential for creating new active ingredients.
Note: The specific applications and reasons for use are placeholders and should be replaced with actual details based on the materials provided or additional research if necessary.
Check Digit Verification of cas no
The CAS Registry Mumber 170804-18-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,8,0 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 170804-18:
(8*1)+(7*7)+(6*0)+(5*8)+(4*0)+(3*4)+(2*1)+(1*8)=119
119 % 10 = 9
So 170804-18-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H10F3NO2/c1-2-12-5(11)3-4(10)6(7,8)9/h4H,2-3,10H2,1H3
170804-18-9Relevant academic research and scientific papers
BICYCLOHEPTANE PYRROLIDINE OREXIN RECEPTOR AGONISTS
-
Paragraph 0544; 0546, (2022/03/02)
The present invention is directed to bicyclo[4.1.0]heptane pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Ethyl-4,4,4-trifluoroacetoacetate (ETFAA), a powerful building block for enantiopure chirons in trifluoromethyl-β-amino acid series
Michaut, Valérie,Metz, Fran?ois,Paris, Jean-Marc,Plaquevent, Jean-Christophe
, p. 889 - 895 (2008/03/14)
Herein are studied new transformations of ethyl-4,4,4-trifluoroacetoacetate (ETFAA), giving access to a series of enantiopure chirons bearing both a trifluoromethyl group and an amino moiety. The key intermediate is obtained optically pure by a resolution
A convenient synthesis of perfluoroalkylated enamines and vinyl phosphonates
Cen, Wenbiao,Ni, Yuhua,Shen, Yanchang
, p. 161 - 164 (2007/10/02)
The reaction of fluoroalkynes with ammonia and benzylamine gave perfluoroalkylated enamines predominantly as the Z isomer, which were hydrogenated with palladium on carbon to afford perfluoroalkylated β-amino acids in good yield.The reaction of fluoroalky
